Search

Your search keyword '"Mukohara T"' showing total 184 results

Search Constraints

Start Over You searched for: Author "Mukohara T" Remove constraint Author: "Mukohara T"
184 results on '"Mukohara T"'

Search Results

1. PI3K mutations in breast cancer: prognostic and therapeutic implications

2. 264P Increased membrane HER3 expression in brain metastases compared to primary tumors in breast cancer

3. 534P A pilot study of neoadjuvant olaparib for patients with HRD-positive advanced ovarian cancer

4. 256P Difference of immunological status and response to immune checkpoint inhibitor between recurrent and de novo stage IV HER2-negative breast cancer in NEWBEAT trial (WJOG9917BTR)

5. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

9. LBA4 Datopotamab deruxtecan (Dato-DXd), a TROP2-directed antibody-drug conjugate (ADC), for triple-negative breast cancer (TNBC): Preliminary results from an ongoing phase I trial

13. 346P Phase I study of the liposomal formulation of eribulin (E7389-LF): Results from the HER2-negative breast cancer expansion

14. 583P Effect of infusion rate, premedication, and prophylactic peg-filgrastim treatment on the safety of the liposomal formulation of eribulin (E7389-LF): Results from the expansion part of a phase I study

15. Abstract OT1-12-02: Biomarker study of patients with HER2-negative metastatic breast cancer receiving combination therapy with nivolumab, bevacizumab and paclitaxel as first-line treatment (WJOG9917BTR)

22. Pathophysiological Role of Cachexia in Patients with Advanced Pancreatic Cancer

24. Dacarbazine Mono-Therapy for Unresectable Neuroendocrine Tumor: A Retrospective Analysis

34. Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer

41. Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations.

42. Japanese experience with second-line chemotherapy with low-dose (60 mg/M2) docetaxel in patients with advanced non-small-cell lung cancer.

47. Cutaneous endometrial cancer arising from heterotopic endometriosis in an abdominal caesarean section scar.

Catalog

Books, media, physical & digital resources